EC targets price and class for harmonisation
Medicines should cost the same and have the same legal classification throughout Europe, according to the European Commission.
Erkki Liikanen, European Commissioner for Enterprise and Innovation,
told the AESGP meeting: “We want to integrate further the market
in self-medication products.”
Mr Liikanen said that the different legal classification of medicines
in different member states of the European Community was a problem for
the pharmaceutical industry. “We need greater consistency in the
interests of the single European market.”
Mr Liikanen pointed out that different national decisions were made from
the same rules.
The commission also wants to see price controls removed from medicines.
Mr Liikanen said: “We are looking forward to constructive input
on the issue of pricing regulation is some states.”
Earlier, Irene Sacristán Sánchez, from the commission’s
enterprise directorate, said that the commission had wanted to include
the legal status of medicines in this year’s revised mutual recognition
procedures. |